Drug Development and Clinical Trials for Lymphoma and CLL/SLL | LRF Webinars

Update on Relapsed/Refractory CLL/SLL | LRF WebinarsПодробнее

Update on CLL for Newly Diagnosed Patients | LRF WebinarsПодробнее

Update on Relapsed/Refractory CLL/SLL | LRF WebinarsПодробнее

Update on Oral Therapies in Lymphoma and CLL | LRF WebinarsПодробнее

Update on CLL/SLL for Newly Diagnosed Patients | LRF WebinarsПодробнее

Understanding CAR T Cell Therapy and Lymphoma | LRF WebinarsПодробнее

Update on Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | LRF WebinarsПодробнее

Clinical Trials As a CLL Treatment Option: What You Should KnowПодробнее

Caregivers and CAR T Cell Therapy | LRF WebinarsПодробнее

WMUK Webinar - Clinical TrialsПодробнее

Understanding clinical trialsПодробнее

Why are clinical trials in lymphoma important?Подробнее

Canadian Clinical Trials and Access for Lymphoma PatientsПодробнее

Virtual Series Session 1 CLL SLL Multiple MyelomaПодробнее

Update on Hodgkin Lymphoma | LRF WebinarsПодробнее

Understanding A Lymphoma Diagnosis | LRF WebinarsПодробнее

Oral Therapies and Adherence in Lymphoma and CLL | WebinarsПодробнее

CLL Clinical Trials ExplainedПодробнее

Lymphoma Clinical Trials and New Treatment Options | Dana-Farber Cancer InstituteПодробнее

Update on Oral Therapies | LRF WebinarsПодробнее